Journal of Cancer Research and Therapeutics Close
 

Figure 2: Evaluation of the viability of MDA-MB-231 cells in response to morphine, single radiation dose of 2 Gy, and a combination of both at (a) 24 h and (b) 72 h, using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay. MDA-MB-231 cells were treated as indicated. Data are mean ± standard deviation where control is set at 100% (n = 3). The asterisks indicate a statistically significant difference versus control, and the hashtags indicate a statistically significant difference of specific dose of morphine + radiation (2 Gy) versus radiation alone (2 Gy) (P ≤ 0.05)

Figure 2: Evaluation of the viability of MDA-MB-231 cells in response to morphine, single radiation dose of 2 Gy, and a combination of both at (a) 24 h and (b) 72 h, using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay. MDA-MB-231 cells were treated as indicated. Data are mean ± standard deviation where control is set at 100% (<i>n</i> = 3). The asterisks indicate a statistically significant difference versus control, and the hashtags indicate a statistically significant difference of specific dose of morphine + radiation (2 Gy) versus radiation alone (2 Gy) (<i>P</i> ≤ 0.05)